Navigation Links
Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
Date:10/17/2007

GAITHERSBURG, Md., Oct. 17 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. announced today that BC Detect(SM), the Company's serum-based breast cancer diagnostic test, is now available from Panacea Laboratories. BC Detect(SM) is a simple blood test that should facilitate the identification of recurrence among women successfully treated for breast cancer. Panacea Laboratories, a division of Panacea Pharmaceuticals, is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). The blood sample can be ordered by any physician and sent to Panacea for testing; sample and shipping requirements are available at http://www.panacea-labs.com.

Breast cancer is the most common type of cancer in women accounting for 26% of female cancers. One in every eight women will develop breast cancer in their lifetime, placing the lifetime risk at 13%. More than 200,000 new cases of breast cancer will be diagnosed in the United States in 2007 and upwards of 2 million women are currently breast cancer survivors. Five-year survival rates for breast cancer are 98% for localized disease, 83% for regionally spread and 26% for distantly spread cancer. However, 25% of all metastases occur more than 5 years after the initial diagnosis and thus survival rates decrease as time goes out to 10 years due to disease recurrence. Methods to detect initial presentation of breast cancer as well as recurrence rely on imaging modalities, including mammography and MRI. No serum biomarkers have been approved for either primary breast cancer screening or monitoring for disease recurrence primarily due to relatively low specificities and sensitivities. In asymptomatic women in remission from breast cancer the guidelines of the major oncologic organizations only suggest annual mammography for detection of new tumors.

BC Detect(SM) measures levels of human aspartyl (asparaginyl) beta- hydroxylase (HAAH), a cancer molecular
'/>"/>

SOURCE Panacea Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biomarkers - Technologies, ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... in manufacturing equipment, to creating professional commercial video content, to analysis of athletic ... of fascinating events that go by too quickly to process with the naked ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... Conn., May 20 Biodel Inc. (Nasdaq:,BIOD) today announced ... Chief Medical Officer, effective May 27, 2008., "The ... with strong,internal clinical and regulatory leadership and we expect ... of our product candidates," said,Dr. Solomon Steiner, Chief Executive ...
... McHENRY, Ill., May 20 Turtle Island ... Food soups fortified with ingredients shown to ... ( http://www.ganedenlabs.com/index.html )., The new Souper ... GanedenBC30,(Bacillus coagulans GBI-30, 6086),( http://www.ganedenlabs.com/ourScience.html ), a ...
... of Two-Phase Examination of U.S. Asthma Control, RESEARCH ... half of adult Americans with asthma and more than ... nationally representative survey do,not have their disease well controlled, ... at the International Conference of the American,Thoracic Society meeting ...
Cached Biology Technology:Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 3Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 3
(Date:8/18/2015)... N.J. , Aug. 18, 2015 /PRNewswire/ ... a key contributor to the Submission Content ... by IRISS, a non-profit forum. Dedicated to the ... provides a neutral platform for industry, vendors, ... share information and work towards a standard ...
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that four of its ... solution, have officially been named FIDO Certified™ by ... of the certification, Synaptics, Natural ID™ fingerprint solutions ... Authentication Framework (UAF) standard and are interoperable among ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... LOUISVILLE, Ky. Excess abdominal fat can be a ... diabetes and cancer. A person,s measure of belly fat ... hip circumference, and it is estimated that genetics account ... Taylor, Ph.D., M.S., assistant professor, University of Louisville School ...
... epilepsy researchers has reported the discovery of a new ... combination of technologies, including trio exome sequencing of patient/parental ... zebrafish, the EuroEPINOMICS RES consortium found that mutations in ... epilepsy patients with symptoms similar to Dravet syndrome ...
... pharma- cologists test different active ingredients and chemical compounds. ... cells react to these substances. To do so, researchers ... graphic images, i.e. computer-generated holograms in which the cells ... The hologram is first created as an optical image, ...
Cached Biology News:UofL epidemiologist uncovers new genes linked to abdominal fat 2European epilepsy consortium identifies new gene for severe childhood epilepsy 2European epilepsy consortium identifies new gene for severe childhood epilepsy 3European epilepsy consortium identifies new gene for severe childhood epilepsy 4Faster testing of new pharmaceuticals 2Faster testing of new pharmaceuticals 3
...
... TFT color screen, without Camera • ... with 8.0 mega pixel resolution. It is computer ... View image from large 5.6" TFT color liquid ... suitable to capture image for fluorescent gels, colorimetric ...
... RapidTrace SPE Workstation is a modular, highly ... platform. Utilizing 1ml or 3ml industry standard ... to 100 samples in less than two ... with 10 cartridges, and up to 10 ...
... Small space saving design - ideal for personal use ... , - 3D gyratory action SSM3 , - ... control and built-in timer , Optional tier system available ... where gentle mixing is required, either on the bench ...
Biology Products: